scorecardresearch
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
CORONAVIRUS

CORONAVIRUS

Updated : May 02, 2024

'Covaxin was developed with safety focus’: Bharat Biotech on Covishield blood clot row

AstraZeneca has said that in “very rare cases”, its Covid-19 vaccine can cause low platelet count and a blood clot-related side effect – Thrombosis Thrombocytopenia Syndrome (TTS)

Updated : May 01, 2024

'India continued with Covishield even after adverse reports': AAP's Saurabh Bharadwaj targets Centre as AstraZeneca admits side effect

The AAP leader's remarks came a day after British pharma giant AstraZeneca admitted in a UK court that its anti-COVID vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases." 

Updated : May 01, 2024

'Sympathy goes out to anyone who lost loved ones,' says AstraZeneca on Covishield row

The admission came a day after the pharma giant admitted in a UK court that its COVID-19 vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases". 

Updated : Apr 30, 2024

AstraZeneca's admission of Covishield risk may spark legal battles in India

The vaccine producer stated in court documents that the inoculation could occasionally induce Thrombosis with Thrombocytopenia Syndrome (TTS), a disorder resulting in blood clots and a reduced platelet count, as reported in The Telegraph.

Updated : Mar 07, 2024

Persistent Covid infections may be more common than expected: Report

The researchers estimate that between one in a thousand to one in 200 of all infections may become persistent, and last for at least 60 days

Updated : Mar 06, 2024

No impact on immune system of man who received over 200 COVID-19 vaccinations: Lancet study

A German man who claimed to have received 217 COVID-19 vaccinations has been examined by researchers and found to have a fully functional immune system.

Advertisement